WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (Nasdaq: NURO) announced that Frank McGillin, Senior
Vice President and General Manager, Consumer will participate in a panel
titled "Wearables: Sleeker Smarter Faster" on Thursday, January 7 at
4:30pm (Pacific) at the 2016 CES Event in Las Vegas. Jane
Francisco, Editor-in-Chief, Good Housekeeping will moderate the panel.
Mr. McGillin will join other industry leaders including Dr. Arshya
Vahabzadeh, Innovation Officer and Physician, M.G.H./Harvard Medical
School, Jorge Valdes, EVP, Chief Technical Officer, Dexcom Inc., Laurel
A. Christensen, Ph.D., Chief Audiology Officer, GN ReSound Group and Dr.
David L. Katz, Director, Yale-Griffin Prevention Research Center.
"CES is known for being at the cutting edge of consumer technology,"
said Mr. McGillin. "To become an indispensible part of our lives, future
wearables will need to deliver relevant functionality that goes beyond
the simple tracker and are designed to integrate seamlessly in your
life. Products like Quell® are a good example of what is
possible."
CES is the largest consumer technology event and has served as the
launch pad for innovators and breakthrough technologies for almost 50
years. CES attracts global business leaders and pioneering thinkers to a
forum where the industry's most relevant issues are addressed.
CES attendees will have an opportunity to learn about Quell, the
NeuroMetrix wearable device for treating chronic pain. The Company will
offer a first glimpse of the latest generation of Quell technology at
Booth # 73313 in the Digital Health section of CES.
About Quell
Quell utilizes NeuroMetrix's patented neurostimulation technology to
provide widespread relief from chronic pain. The advanced wearable
device is lightweight and can be worn during the day while active, and
at night while sleeping. It has been cleared by the FDA for treatment of
chronic pain without a prescription. In a recent study, 81% of Quell
users reported an improvement in their chronic pain. Quell includes a
smartphone app that tracks and personalizes their pain therapy. It is
available for purchase at QuellRelief.com,
selected retailers and healthcare professionals.
About NeuroMetrix
NeuroMetrix is an innovative healthcare
company that develops wearable medical technology and point-of-care
tests that help patients and physicians better manage chronic pain,
nerve diseases, and sleep disorders. The company is located in Waltham,
Massachusetts and was founded as a spinoff from the Harvard-MIT Division
of Health Sciences and Technology in 1996. For more information, please
visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160104006008/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
